XML 20 R4.htm IDEA: XBRL DOCUMENT v3.21.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Net Sales $ 15,988 $ 15,280 $ 46,599 $ 47,033
Cost of Sales 16,317 14,934 46,788 44,693
Gross (Loss) Profit (329) 346 (189) 2,340
Research and Product Development 1,221 1,745 5,445 5,183
Selling and Marketing 1,541 1,669 4,860 5,738
General and Administrative 3,881 3,622 11,483 11,767
Operating Loss (6,972) (6,690) (21,977) (20,348)
Other (Expense) Income        
Realized (Loss) Gain on Investments 0 4 (1) 8
Warrant Modification Expense 0 0 0 (837)
Interest Expense (609) (666) (1,772) (1,289)
Interest Income 0 2 17 239
Total Other Expense (609) (660) (1,756) (1,879)
Net Loss $ (7,581) $ (7,350) $ (23,733) $ (22,227)
Basic Net Loss per Share (in dollars per share) $ (0.08) $ (0.10) $ (0.26) $ (0.32)
Diluted Net Loss per Share (in dollars per share) $ (0.08) $ (0.10) $ (0.26) $ (0.32)
Basic Weighted Average Shares Outstanding (in shares) 93,882,142 71,811,322 93,726,629 69,594,167
Diluted Weighted Average Shares Outstanding (in shares) 93,882,142 71,811,322 93,726,629 69,594,167